DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactCompany

GPT Healthcare Limited — Analysts/Institutional Investor Meet/Con. Call Updates

NSE 3 hrs ago·4 Aug 2026, 8:41 am

GPT Healthcare

GPT Healthcare Limited has informed the stock exchanges about the recording of a significant meeting with analysts and institutional investors. This update confirms that the company has completed the necessary regulatory filing to document the proceedings of the event.

For investors, this development is a routine but positive signal. It indicates that the company is actively engaging with the financial community to discuss its business performance and future outlook. Such meetings often provide the market with clarity on management strategy and operational health.

Moving forward, investors should watch for any specific disclosures made by the company during this interaction. While the immediate update is procedural, the substance of the discussion could offer insights into the company's growth trajectory and upcoming projects.